Showing results (1091-1100 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|June 24, 2022
High dose (conditioning) regimens used prior to autologous stem cell transplantation in multiple myelomaMohammad O Ali, Samer Al Hadidi
Transplantation and Cellular Therapy|May 30, 2021
Hepatitis B Seropositive Status in Recipients or Donors Is Not Related to Worse Outcomes after Haploidentical Hematopoietic Stem Cell TransplantationChunzi Yu, Yuqian Sun, Lanping Xu, et al.
Transplantation and Cellular Therapy|July 2, 2021
Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft RecipientsRoni Tamari, Samantha Brown, Sean M Devlin, et al.
Transplantation and Cellular Therapy|July 4, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms reportDaniel Wolff, Vedran Radojcic, Robert Lafyatis, et al.
Transplantation and Cellular Therapy|July 4, 2021
Sequential Organ Failure Assessment Score and the Need for Organ Support Predict Mortality in Allogeneic Stem Cell Transplant Patients Admitted to the Intensive Care UnitCándido Díaz-Lagares, Laura Fox, Alejandra García-Roche, et al.
Transplantation and Cellular Therapy|July 6, 2021
A Scoring System for Predicting the Prognosis of Late-Onset Severe Pneumonia after Allogeneic Hematopoietic Stem Cell TransplantationLe-Qing Cao, Jing-Rui Zhou, Xiao-Hui Zhang, et al.
Transplantation and Cellular Therapy|June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular TherapyKatherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
Transplantation and Cellular Therapy|July 5, 2021
Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic SyndromeThierry Guillaume, Sylvain Thépot, Pierre Peterlin, et al.
Transplantation and Cellular Therapy|September 19, 2020
Outcomes of Autologous Hematopoietic Cell Transplantation in Diffuse Large B Cell Lymphoma Refractory to Firstline ChemoimmunotherapySusan Bal, Luciano J Costa, Craig Sauter, et al.
Transplantation and Cellular Therapy|September 21, 2020
Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic TransplantationNarendranath Epperla, Kwang W Ahn, Manoj Khanal, et al.
Pageof 183